- Home
- TLSI vs BHR Comparison
TLSI vs BHR Comparison
Compare TLSI & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- BHR
- Stock Information
- Founded
- TLSI 2010
- BHR 2013
- Country
- TLSI United States
- BHR United States
- Employees
- TLSI N/A
- BHR N/A
- Industry
- TLSI Medical Specialities
- BHR Real Estate Investment Trusts
- Sector
- TLSI Health Care
- BHR Real Estate
- Exchange
- TLSI Nasdaq
- BHR Nasdaq
- Market Cap
- TLSI 160.4M
- BHR 187.7M
- IPO Year
- TLSI N/A
- BHR N/A
- Fundamental
- Price
- TLSI $5.74
- BHR $1.91
- Analyst Decision
- TLSI Strong Buy
- BHR
- Analyst Count
- TLSI 6
- BHR 0
- Target Price
- TLSI $11.75
- BHR N/A
- AVG Volume (30 Days)
- TLSI 57.4K
- BHR 363.7K
- Earning Date
- TLSI 05-14-2025
- BHR 05-07-2025
- Dividend Yield
- TLSI N/A
- BHR 10.23%
- EPS Growth
- TLSI N/A
- BHR N/A
- EPS
- TLSI N/A
- BHR N/A
- Revenue
- TLSI $29,431,000.00
- BHR $726,796,000.00
- Revenue This Year
- TLSI $55.08
- BHR N/A
- Revenue Next Year
- TLSI $50.75
- BHR $3.07
- P/E Ratio
- TLSI N/A
- BHR N/A
- Revenue Growth
- TLSI 58.99
- BHR N/A
- 52 Week Low
- TLSI $3.50
- BHR $1.83
- 52 Week High
- TLSI $10.24
- BHR $3.95
- Technical
- Relative Strength Index (RSI)
- TLSI 59.91
- BHR 26.47
- Support Level
- TLSI $5.23
- BHR $1.83
- Resistance Level
- TLSI $5.66
- BHR $2.13
- Average True Range (ATR)
- TLSI 0.34
- BHR 0.17
- MACD
- TLSI 0.03
- BHR -0.04
- Stochastic Oscillator
- TLSI 92.94
- BHR 9.88
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.